PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.\', \'Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.\', \'German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.\', \'German Cancer Research Center (DKFZ), Heidelberg, Germany.\', \'National Center for Tumor Diseases (NCT) Partner Site Dresden, Dresden, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/febs.15499
?:hasPublicationType
?:journal
  • The FEBS journal
is ?:pmid of
?:pmid
?:pmid
  • 32738184
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tumor markers as an entry for SARS-CoV-2 infection?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all